Navigation Links
NeoStem Announces Private Placement Financing to Advance Marketing Campaign; Financing Includes Investment from New England Cryogenic Center
Date:5/21/2008

NEW YORK, May 21 /PRNewswire-FirstCall/ -- NeoStem, Inc. (Amex: NBS), which is pioneering the pre-disease collection, processing and long-term storage of adult stem cells for future medical need, today announced a private placement financing in a total amount of $900,000, which includes a strategic investment from the New England Cryogenic Center, Inc. (NECC), one of the largest full-service cryogenic laboratories in the world.

The financing consists of units priced at $1.20 per unit with each unit consisting of one share of common stock and a warrant to purchase one share of common stock at $1.75 per share.

Robin Smith, MD, MBA, NeoStem's CEO, stated, "We are pleased to announce this new financing, which included investments from both NECC and NeoStem management. These funds will be instrumental in executing on our plan to educate potential clientele about our services, particularly in the Northeast which we believe will be a powerful market. We look forward to working closely with NECC, a strategic partner since October 2007 and located in Massachusetts, to provide extensive new stem cell processing and storage capabilities on the East Coast as well as to embark on a marketing campaign to NECC customers."

On May 9, 2008, NECC was granted a license from the State of New York to process, store and use for research adult hematopoietic stem cells collected from New York residents. NECC's New York licensure will provide NeoStem with greatly expanded storage capacity for one of its largest potential markets and facilitate expanded relationships with leading physician practices.

"We are excited to expand our laboratory offerings to NeoStem in connection with this exciting new project and plan to offer NeoStem's servi
'/>"/>

SOURCE NeoStem, Inc.
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related biology technology :

1. NeoStem to Expand Stem Cell Collection Center Network to Florida
2. NeoStem Featured in WCBS-TV Health Watch Segment on Adult Stem Cells
3. NeoStems Denis Rodgerson, Ph.D. to Lecture on Stem Cells and Regenerative Medicine at University of Nevada Las Vegas Campus
4. NeoStem to Present at Third Annual Stem Cell Summit in New York City
5. NeoStem Announces NY State License for Adult Stem Cell Collection
6. Rentschler Biotechnologie Announces Cooperation with Boehringer Ingelheim
7. Still River Systems Announces Operation of the Worlds Highest Magnetic Field Cyclotron
8. Aton Pharma Announces Distribution Partnership in the Asia Pacific Region
9. Daiichi Sankyo Co., Ltd. Announces Acquisition of Biotech Firm U3 Pharma AG
10. eResearchTechnology Announces Resignation of its CFO
11. Biodel Inc. Announces Appointment of Alan Krasner, M.D. as Chief Medical Officer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/18/2013)...  AMRI (NASDAQ: AMRI ) announced ... , site has received approval to expand its ... handle Schedule 2 and 2N controlled substances. The ... Burlington,s physical security and quality systems, ... http://photos.prnewswire.com/prnh/20120229/NY61160LOGO ) With its ...
(Date:6/18/2013)... , June 18, 2013 Mapi Pharma ... generic and innovative intermediates, and finished dosage forms based on ... been granted a United States patent ... Europe for the oral treatment of moderate-to-severe ... titled Intermediate Compounds and Processes for the Preparation of ...
(Date:6/18/2013)... 2013 This webinar will examine ... and promotion, and review the basic FDA regulations ... to apply these principles through real world case ...     The fundamentals on FDA regulations and guidance related ...     Assessing traditional and newer forms of promotional ...
(Date:6/18/2013)... DUBLIN , June 18, 2013 /PRNewswire/ ... http://www.researchandmarkets.com/research/4b8vj2/injectable_drug ) has announced the addition of ... Formulations [Liposomes, Microspheres, & Nanoparticles], Devices [Disposables ... Free & Auto Injectors] & Therapeutics [Diabetes ... report to their offering. ...
Breaking Biology Technology:AMRI Burlington Receives DEA Approval to Handle Controlled Substances 2Mapi Pharma Granted United States Patent for Pain Relief Medication "Tapentadol" 2Drug Advertising and Promotion Labeling: FDA Regulations, New Webinar Hosted by Xtalks 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 2Injectable Drug Delivery Market by Formulations, Devices & Therapeutics - Global Forecasts to 2017 3
... the world-leading publisher of scientific, technical and medical ... 2009: The First International Conference on Multifunctional, Hybrid ... France, 15-19 March 2009. , Research in ... in published papers in recent years with increasing ...
... DNDN ) will release its fourth quarter financial results on,Thursday, March ... PT; 11:00 a.m. ET to review fiscal year 2007 financial results,and ... follows:, Time: 11:00 AM ... March 13, 2008 Dial-in: 1-877-548-7901 (domestic) or +1-719-325-4844 ...
... WYE ),confirmed today that it will appeal the verdicts ... District Court, Eastern District of,Arkansas, beginning with post-trial motions., ... award or for the earlier,compensatory damage award. We will pursue ... necessary. We are confident in,our position on appeal," says Lyn ...
Cached Biology Technology:Hybrid materials: Exciting interdisciplinary field offering future solutions for industry 2-Dendreon to Hold Conference Call on Thursday, March 13, 2008 at 11:00 AM ET- 2Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts 2Wyeth To Appeal Arkansas Hormone Therapy Trial Verdicts 3
(Date:6/17/2013)... MANHATTAN, KAN. -- A Kansas State University research associate ... on mosquitoes and ways to prevent the spread of ... received the National Institutes of Health,s National Research Service ... years. He is the seventh Kansas State University researcher ... on campus to currently hold such an award. , ...
(Date:6/17/2013)... method of mining shale gas, is widespread across Pennsylvania, ... New research in the Annals of the New ... to biodiversity including pollution from toxic chemicals, the building ... , "Shale gas has engendered a great deal of ... but effects on biological diversity and resources have scarcely ...
(Date:6/16/2013)... A mechanism that cells use to group together and move ... been described for the first time by scientists at UCL. ... new study focuses on the process that occurs when cancer ... the body during metastasis. Scientists know that cancer cells recruit ... how this process takes place and how it could be ...
Breaking Biology News(10 mins):NIH fellowship helps researcher fight malaria, understand mosquito immunity 2'Chase and run' cell movement mechanism explains process of metastasis 2
... bathers and boaters in the Chesapeake Bay on the United ... coasts. A new study by researchers at the Virginia ... a more significant impact, drastically altering marine food webs by ... the size and frequency of jellyfish blooms in coastal and ...
... least known type of gorilla will receive a helping hand ... Society a $150,000 grant to help save the Grauer,s gorilla ... The grant will help equip and support park ... of Kahuzi-Biega National Park, a World Heritage site that is ...
... of invasion biology faces a new challenge as 19 ... against non-native species" in the journal Nature . ... say that non-native species could just as easily be ... The authors of the Nature comments section note ...
Cached Biology News:Jellyfish blooms transfer food energy from fish to bacteria 2Jellyfish blooms transfer food energy from fish to bacteria 3Wildlife Conservation Society receives $150,000 grant from Newman's Own Foundation to save gorillas 2Ecology biased against non-native species? 2
STX18 Immunogen: STX18 (NP_058626, 101 a.a. ~ 200 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Mouse monoclonal [CLB-SW16 (formerly 708)] to CD42d (rating: ****) ( Abpromise for all tested applications). entrezGeneID: 2814 SwissProtID: P40197...
Request Info...
Anti-Bcl-G (CT) Host: rabbit polyclonal Species Reactivity: human, mouse, rat Applications: WB, IHC Storage: 4C...
Biology Products: